摘要
大麻是一种草本植物。大量的动物实验研究证明，大麻类物质具有止痛、镇静、抗痉挛、抗呕吐、抗青光眼以及抗高血压等多种药理作用。由于机体对大麻类物质有一定的耐受性和成瘾性，因此其临床应用受到严格限制。70年代，有人报道，大麻可能会降低机体抗病毒感染的能力，甚至导致免疫无应答综合征。90年代初，大麻类物质的中枢型受体和外周型受体相继克隆成功．几种内源性大麻先后被发现。近些年来，国外有学者开始认识到大麻素能诱导神经系统肿瘤（特别是胶质瘤）细胞的凋亡，
出处
《中国临床神经外科杂志》
2007年第3期185-189,共5页
Chinese Journal of Clinical Neurosurgery
参考文献42
-
1Razdan RK. Structure-activity relation in cannabinoids [J].Pharmacol Rew, 1986, 38: 75-149.
-
2Klein TW, Newton C, Friedman H. Cannabinoid receptors and immunity [J]. Immunol Today, 1998, 19: 373-381.
-
3Matsuda LA, Lolait SJ, Brownstein M J, et al. Structure of a cannabinoid receptor and a functional expression of the cloned cDNA [J]. Nature, 1990, 346: 561-564.
-
4Munro S, Thomas KL, Abu-shaa M, et al. Molecular characterization of a peripheral receptor for cannabinoids [J].Nature, 1993, 356: 61-65.
-
5Breivogel CS, Griffin G, Di Matzo V, et al . Evidence for a new G protein coupled cannabinoid receptor in mouse brain[J]. Mol Pharmacol, 2001, 60: 155-163.
-
6Hajos N, Ledent C, Freund TF. Novel cannabinoid-sensitive receptor mediates inhibition of glutamagtergic synaptic transmission in the hippocampus [J]. Neuroscience, 2001,106: 1-4.
-
7Howlett AC. Inhibition of neuroblastoma adenylate cyclase by cannabinoid and nantradol compounds [J]. Life Sci,1984, 35: 1803-1810.
-
8Pertwee RG. Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development [J]. Exp Opin Invest Drugs,2000, 9: 1-19.
-
9Porter AC, Felder CC. The endocannabinoid nervous system: unique opportunities for therapeutic intervention [J].Pharmacol Ther, 2001, 90: 45-60.
-
10Wartmann M, Campbell D, Subramanian A, et al. The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide [J]. FEBS Lett, 1995,359: 133-136.
同被引文献8
-
1陈兴平,张杏平.TAP1及其mRNA在尖锐湿疣皮损中的表达[J].中国麻风皮肤病杂志,2005,21(3):172-174. 被引量：2
-
2Scheurer ME,Tortolero-Luna G,Adler-Storthz K.Human papillomavirus infection:biology,epidemiology,and prevention[J].Int J Gynecol Cancer,2005,15(5):727-746.
-
3Ramer R,Hinz B.Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1[J].J Natl Cancer Inst,2008,100(1):59-69.
-
4Sami Sarfaraz,Farrukh Afaq,Vaqar M.Adhami and Hasan Mukhtar.Cannabinoid Receptor as a Novel Target for the Treatment of Prostate Cancer[J].American Association for Cancer Research,2005,65:1635-1641.
-
5Valdespino VM,Valdespino VE.Cervical cancer screening:state of the art[J].Curr Opin Obstet Gynecol,2006,18(1):35-40.
-
6Sami S,Vaqar M,Deeba N,et al.Cannabinoids for cancer treatment:progress and promise[J].Cancer Res,2008,68(2):339-342.
-
7Blázquez C,Carracedo AK,Barrado LL,et al.Cannabinoid receptorsas novel targets for the treatment of melanoma[J].FASEB J,2006,12 (20):1-10.
-
8赵梓纲,赵华,李恒进.大麻素Ⅱ型受体(CB2)在人皮肤及皮肤恶性肿瘤的组织分布[J].细胞与分子免疫学杂志,2008,24(1):67-68. 被引量：2
-
1谭真,黄德嘉.内源性大麻系统与代谢综合征[J].中华心血管病杂志,2006,34(6):568-570. 被引量：1
-
2王雷.恩丹西酮复合地塞米松预防妇科手术后恶心呕吐的临床观察[J].首都医药,2006,13(16):39-39.
-
3耿志宇,王东信,刘英华.托烷司琼和昂丹司琼预防妇科腹腔镜术后恶心呕吐的比较[J].中国新药杂志,2009,18(24):2316-2319. 被引量：7
-
4高文学,王林安,于玲珠,高利.异丙酚的临床应用[J].黑龙江畜牧兽医,2002(9):51-52. 被引量：2
-
5夏训明.美国FDA加强对乙酰氨基酚剂量的控制以降低其肝脏毒性[J].广东药学院学报,2011,27(1):17-17. 被引量：1
-
6方丽华,孙建斌,徐洋.常见革兰阴性杆菌对氨曲南的耐药性分析[J].中华医院感染学杂志,2007,17(4):450-451. 被引量：10
-
7张向农.醋酸甲地孕酮与大麻屈酚改善晚期癌症病人食欲减退的疗效比较[J].国外医学（肿瘤学分册）,2002,29(4):320-320.
-
8王会忠,王震,仲海洋.雷替曲塞联合奥沙利铂治疗晚期胃癌的疗效观察[J].中国肿瘤临床与康复,2015,22(8):940-942. 被引量：4
-
9孙海艳,袁亚敏,魏绍斌.HPV感染与宫颈癌的预防[J].江西中医药,2006,37(9):11-12. 被引量：8
-
10赵梓纲,李园园,杨洁,李恒进,赵华.大麻素2型受体在皮肤鳞状细胞癌的表达[J].南方医科大学学报,2010,30(3):593-595. 被引量：3
